Drug intelligence / Profile preview

fentanyl + morphine + hydromorphone + hydrocodone + acetaminophen + ketorolac + gabapentin + ketamine + ibuprofen

Development stage
Unknown
Lead developer
Janssen Pharmaceutica
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular, Subcutaneous, Transdermal, Intranasal, Sublingual, Rectal, Topical, Ophthalmic, Intrathecal, Epidural, Buccal
01

Overview

This is a complex combination of multiple pain medications and adjuvants spanning different drug classes. It includes: - **Opioid analgesics**: fentanyl, morphine, hydromorphone, and hydrocodone - **Non-opioid analgesics**: acetaminophen, ketorolac, and ibuprofen - **Adjuvant medications**: gabapentin and ketamine This combination would not typically be administered simultaneously as a single formulation due to the overlapping mechanisms, potential for severe respiratory depression, and other serious adverse effects. Each component has distinct properties: - Fentanyl is a synthetic opioid 50-100 times more potent than morphine - Morphine is considered the archetypal opioid painkiller - Hydromorphone has 2-8 times the potency of morphine - Hydrocodone is commonly prescribed for moderate to severe pain - Acetaminophen is a non-opioid analgesic often combined with opioids - Ketorolac is a non-steroidal anti-inflammatory drug (NSAID) - Ibuprofen is another NSAID - Gabapentin is an anticonvulsant with pain-relieving properties - Ketamine is a dissociative anesthetic with analgesic properties

02

Targets

DOR (Opioid Receptor Delta 1)CACNA2D1 (Voltage-gated calcium channel subunit alpha2/delta-1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)MOR (Mu opioid receptor)CACNA2D2 (α2δ-2)KOR (Kappa opioid receptor)NMDAR (Glutamate receptor ionotropic, NMDA)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on fentanyl + morphine + hydromorphone + hydrocodone + acetaminophen + ketorolac + gabapentin + ketamine + ibuprofen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fentanyl + morphine + hydromorphone + hydrocodone + acetaminophen + ketorolac + gabapentin + ketamine + ibuprofen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call